Vena Vitals develops VeriTrack, a continuous blood pressure monitoring system that uses a skin sensor placed over a palpable artery. The company says the product provides real-time blood pressure monitoring comparable to an arterial line, with use in operating rooms, hospitals, clinics, and home settings. The website states the VeriTrack system was recently submitted for FDA 510(k) evaluation.
The main competitors of Vena Vitals in the blood pressure monitoring market include:
DispatchHealth: This company provides in-home medical care, including monitoring and treatment for high blood pressure. Their advantage lies in offering personalized care at home, which can be more convenient for patients who may struggle with traditional clinic visits. They focus on immediate care for hypertensive crises and other conditions, making them a strong competitor in the home healthcare space.
Strados Labs: Although specific information about Strados Labs in the context of blood pressure monitoring was not found, they are known for developing remote monitoring solutions that could potentially include blood pressure management. Their technology focuses on continuous monitoring and data collection, which can provide valuable insights for healthcare providers.
Lura Health: Lura Health is developing a non-invasive salivary diagnostic wearable monitor that tracks various health metrics. While their primary focus is not solely on blood pressure, their innovative approach to health monitoring through saliva could position them as a competitor in the broader health monitoring market. Their technology offers a pain-free alternative to traditional methods, which may appeal to users looking for less invasive options.
These competitors highlight different approaches to health monitoring, with DispatchHealth focusing on in-home care, Strados Labs on remote monitoring technology, and Lura Health on non-invasive diagnostics.
Vena Vitals primarily focuses on the healthcare industry, specifically in the market of blood pressure monitoring solutions.